Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Katapult Holdings Reports Mixed Q4 Financial Results and Positive Outlook for 2024

Elaine Mendonca by Elaine Mendonca
March 14, 2024
in Breaking News
0
GD stock news
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Katapult Holdings released its Q4 financial results on March 14, 2024, showcasing a mix of outcomes. The company reported a GAAP EPS of -$4.46, falling short of expectations by $2.67. On the bright side, revenue came in at $56.71 million, exceeding estimates by $0.9 million.

Gross originations for the quarter experienced a 13% increase year-over-year, hitting $67.5 million. Adjusted net loss showed improvement at $6.1 million compared to the previous year, while adjusted EBITDA loss also improved to $0.1 million.

Looking ahead, Katapult Holdings foresees flat year-over-year gross originations growth in Q1 2024, a revenue increase of 12 to 14%, and a significant enhancement in Adjusted EBITDA performance compared to the prior year. For the full year 2024, the company expects continued customer base expansion, gross originations growth of at least 10%, revenue growth of at least 10%, and another year of Adjusted EBITDA growth.

KPLT Stock Plummets 28.37% in Value on March 14, 2024

On March 14, 2024, KPLT stock experienced a significant drop in its price performance. Trading near the bottom of its 52-week range and below its 200-day simple moving average, KPLT opened at $16.90, $1.50 lower than its previous close. Throughout the day, the price of KPLT shares decreased by $5.22, resulting in a 28.37% drop in value since the market last closed.

KPLT Stock Analysis: Revenue Decline but Improving Net Income and EPS

On March 14, 2024, KPLT stock experienced mixed performances based on the financial data provided by CNN Money. The total revenue for the company stood at $212.10 million over the past year, with a significant decrease of 30.02% compared to the previous year. However, the total revenue remained flat since the last quarter, indicating some stability in the company’s revenue stream.

In terms of net income, KPLT reported a net loss of $37.87 million over the past year, which represents a substantial decrease of 278.59% compared to the previous year. However, the net loss improved to -$2.91 million in the third quarter, showing a 54.54% increase since the previous quarter. This improvement in net income from the previous quarter could be a positive sign for investors, as it suggests that the company may be taking steps to address its financial challenges.

Earnings per share (EPS) for KPLT also showed a mixed performance. The company reported an EPS of -$9.64 over the past year, which represents a significant decrease of 246.47% compared to the previous year. However, the EPS improved to -$0.71 in the third quarter, showing a 55.17% increase since the previous quarter. This improvement in EPS from the previous quarter could indicate that the company is making progress in improving its profitability.

Overall, the financial data for KPLT on March 14, 2024, suggests that the company is facing challenges in terms of revenue and net income. However, the improvements in net income and EPS since the previous quarter could be a positive sign for investors. It will be important for investors to closely monitor the company’s financial performance in the coming quarters.

Tags: KPLT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Energy Company Markets and money

FutureFuel Corp Reopens Trading with Focus on Specialty Chemicals and Biofuels

Alternative Energy Stock Market Today

Potential 2 Billion Sale of UK Gas Pipeline Assets by BlackRock and GIC Pte

Finance_Investment (2)

EF Hutton Analyst Reaffirms Buy Rating for FiscalNote Holdings Inc with 5 Price Target

Recommended

Oracle Stock

Oracle Shares Face Sector-Wide Pressure Despite Solid Long-Term Chart

7 months ago
Telecommunications Industry stock Trading

Globalstar Forecasts Strong Financial Performance and Growth Initiatives for 2024

2 years ago
Pulmonx Corp Stock

Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast

5 months ago
Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Trending

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

by Jackson Burston
March 25, 2026
0

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned...

MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase
  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com